Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Jan 15, 2020; 12(1): 83-91
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.83
Table 3 Genomic profiling by tumor type
Total patients profiled, n = 34
Cholangiocarcinoma
Gallbladder carcinoma, n = 2 (6%)
Extrahepatic, n = 5 (15%)
Intrahepatic, n = 27 (79%)
Mutationn (% of profiled)n (% of profiled)n (% of profiled)

TP53-10 (37)2 (100)
IDH1-8 (30)-
KRAS1 (20)6 (22)-
FGFR22 (40)4 (15)-
IDH2-2 (7)-
PBRM1-2 (7)-
BAP1-2 (7)-
NF1-1 (4)1 (50)
ARID1A-1 (4)1 (50)
CDKN2A--1 (50)
MET-1 (4)-
CCND1-1 (4)-
PBX1-1 (4)-
MYC-1 (4)-
RB1-1 (4)-
MAP3K1-1 (4)-
S76-1 (4)-
SPTA1-1 (4)-
RET-1 (4)-
ALK-1 (4)-
ATM-1 (4)-
CCNE1-1 (4)-
GNAS-1 (4)-
SMAD4-1 (4)-
PIK3CA-1 (4)-
PIK3CB-1 (4)-
PTEN-1 (4)-
PALB2-1 (4)-
ARID2-1 (4)-
BRCA2-1 (4)-
BRAF-1 (4)-
MDM21 (20)--
FRS21 (20)--